Ryaltris 25 μg / 600 μg
Ryaltris 25 μg / 600 μg is a medicine authorised by Swissmedic under authorisation number 69672. The authorisation holder is NOBEL Pharma Schweiz AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 June 2025 and the authorisation is limited until 22 June 2030. ATC code R01AD59 places the medicine in the group Nasal preparations.
| Authorisation number | 69672 |
|---|---|
| Name | Ryaltris 25 μg / 600 μg |
| Full name | Ryaltris 25 μg / 600 μg, Nasenspray, Suspension |
| Authorisation holder | NOBEL Pharma Schweiz AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R01AD59 |
| First authorisation | 23 June 2025 |
| Authorisation validity | 22 June 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ryaltris 25 μg / 600 μg, Nasenspray, Suspension | B | 23 June 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 56 | Einzeldose(n) | R01AD59 | 12.02.3. | B |
| 2 | 120 | Einzeldose(n) | R01AD59 | 12.02.3. | B |
| 3 | 240 | Einzeldose(n) | R01AD59 | 12.02.3. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Ryaltris 25 μg / 600 μg authorised in Switzerland?
Yes. Ryaltris 25 μg / 600 μg is authorised by Swissmedic under authorisation number 69672, data as of 01 September 2026. The authorisation is limited until 22 June 2030.
Which dispensing category does Ryaltris 25 μg / 600 μg have?
Ryaltris 25 μg / 600 μg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Ryaltris 25 μg / 600 μg?
The authorisation holder is NOBEL Pharma Schweiz AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.